The purpose of this study is to evaluate the feasibility of using a quantitative EEG method
to evaluate neurodevelopment in newborns and to evaluate whether subtle neurodevelopmental
deficits can be detected in newborns from mothers with gestational diabetes mellitus (GDM)
compared to control newborns.
The second purpose of this study is to determine whether cord blood concentration in
docosahexaenoic acid (DHA), an omega-3 fatty acid, is similar in neonates of well-controlled
mothers with gestational diabetes mellitus (GDM) compared to control mothers, and to evaluate
whether this contributes to neonates neurodevelopment status.